The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Artificial and Bioartificial Support Systems for Acute and Acute-on-Chronic Liver Failure: A Systematic Review
Abstract
CONTEXT: Artificial and bioartificial support systems may provide a "bridge" for patients with severe liver disease to recovery or transplantation. OBJECTIVE: To evaluate the effect of artificial and bioartificial support systems for acute and acute-on-chronic liver failure. DATA SOURCES: Randomized trials on any support system vs standard medical therapy were included irrespective of publication status or language. Nonrandomized studies were included in explorative analyses. Trials were identified through electronic searches (Cochrane Hepato-Biliary Group Controlled Trials Register, Cochrane Library, MEDLINE, EMBASE, and the Chinese Medical Database), bibliographies, and contact with experts. Searches were conducted of the entire databases through September 2002. STUDY SELECTION: Of 528 references identified, 12 randomized trials with 483 patients were included. Eight nonrandomized studies were included in explorative analyses. DATA EXTRACTION: Data were extracted and trial quality was assessed independently by 3 reviewers (L.L.K., J.L., B.A-N.). The primary outcome measure was all-cause mortality. Results were combined on the risk ratio (RR) scale. Random-effects models were used. Sources of heterogeneity were explored through meta-regression and stratified meta-analyses. DATA SYNTHESIS: Of the 12 trials included, 10 assessed artificial systems for acute or acute-on-chronic liver failure and 2 assessed bioartificial systems for acute liver failure. Overall, support systems had no significant effect on mortality compared with standard medical therapy (RR, 0.86; 95% confidence interval [CI], 0.65-1.12). Meta-regression indicated that the effect of support systems depended on the type of liver failure (P =.03). In stratified meta-analyses, support systems appeared to reduce mortality by 33% in acute-on-chronic liver failure (RR, 0.67; 95% CI, 0.51-0.90), but not in acute liver failure (RR, 0.95; 95% CI, 0.71-1.29). Compared with randomized trials, nonrandomized studies produced significantly larger estimates of intervention effects (P =.01). CONCLUSION: This review suggests that artificial support systems reduce mortality in acute-on-chronic liver failure compared with standard medical therapy. Artificial and bioartificial support systems did not appear to affect mortality in acute liver failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
Concato, J., Shah, N., & Horwitz, R. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422507 · Cited by 3,563
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
A comparison of observational studies and randomized, controlled trials.
Benson, K., & Hartz, A. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422506 · Cited by 2,347
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Kjaergard, L. L., Villumsen, J., & Gluud, C. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00010 · Cited by 2,283
Self-citationHiggins (2002) · doi:10.1002/(issn)1097-0258 · Cited by 1,248
Mitzner, S. R., Stange, J., Klammt, S., Risler, T., Erley, C. M., Bader, B. D., Berger, E. D., Lauchart, W., Peszynski, P., Freytag, J., et al. (2000) · Liver Transplantation · doi:10.1002/lt.500060326 · Cited by 717
Statistical Problems in the Reporting of Clinical Trials
Pocock, S. J., Hughes, M. D., & Lee, R. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708133170706 · Cited by 662
Lee, W. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312163292508 · Cited by 546
Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure
O'Grady, J. G., Gimson, A. E. S., O'Brien, C. J., Pucknell, A., Hughes, R. D., & Williams, R. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90011-x · Cited by 538
Pilot–Controlled Trial of the Extracorporeal Liver Assist Device in Acute Liver Failure
Ellis, A. J., Hughes, R. D., Wendon, J. A., Dunne, J., Langley, P. G., Kelly, J. H., Gislason, G. T., Sussman, N. L., & Williams, R. (1996) · Hepatology · doi:10.1002/hep.510240625 · Cited by 513
Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study
Heemann, U. (2002) · Hepatology · doi:10.1016/s0270-9139(02)00102-7 · Cited by 429
Advances in bioartificial liver devices
Allen, J. W., Hassanein, T., & Bhatia, S. N. (2001) · Hepatology · doi:10.1053/jhep.2001.26753 · Cited by 326
CHARCOAL HÆMOPERFUSION IN THE TREATMENT OF FULMINANT HEPATIC FAILURE
Gazzard, B. G., Weston, M. J., Murray-Lyon, I. M., Flax, H., Record, C. O., Portmann, B., Langley, P. G., Dunlop, E. H., Mellon, P. J., Ward, M. B., et al. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90678-3 · Cited by 266
MITZNER, S. R., STANGE, J., KLAMMT, S., PESZYNSKI, P., SCHMIDT, R., & NO[Combining Diaeresis]LDGE-SCHOMBURG, G. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12suppl_1s75 · Cited by 263
(2006) · Hepatology · doi:10.1002/(issn)1527-3350 · Cited by 262
DEANOL IN SPONTANEOUS AND INDUCED DYSKINESIAS
Laterre, E. C., & Fortemps, E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92592-1 · Cited by 253
EARLIER CHARCOAL HAEMOPERFUSION IN FULMINANT HEPATIC FAILURE
Gimson, A. E. S., Mellon, P. J., Braude, S., Canalese, J., & Williams, R. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90711-5 · Cited by 202
Sorkine, P., Abraham, R. B., Szold, O., Biderman, P., Kidron, A., Merchav, H., Brill, S., & Oren, R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00006 · Cited by 154
CONTROLLED TRIAL OF EXCHANGE-TRANSFUSION THERAPY IN FULMINANT HEPATITIS
Redeker, A., & Yamahiro, H. S. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91220-8 · Cited by 147
Tandon, B. N., Bernauau, J., O’Grady, J., Gupta, S., Krisch, R., Liaw, Y., Okuda, K., & Acharya, S. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01905.x · Cited by 120
Evaluation of the BioLogic-DT sorbent-suspension dialyser in patients with fulminant hepatic failure
Hughes, R. D., Pucknell, A., Routley, D., Langley, P. G., Wendon, J. A., & Williams, R. L. (1994) · The International Journal of Artificial Organs · doi:10.1177/039139889401701207 · Cited by 105
Statistical and ethical issues in monitoring clinical trials
Pocock, S. (1993) · Statistics in Medicine · doi:10.1002/sim.4780121512 · Cited by 83
Isoniemi, H., Appelberg, J., Nilsson, C.-G., Mäkelä, P., Risteli, J., & Höckerstedt, K. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00067-2 · Cited by 82
Hemodiabsorption in Treatment of Hepatic Failure
Wilkinson, A. H., Ash, S. R., & Nissenson, A. R. (1998) · Progress in Transplantation · doi:10.1177/090591999800800110 · Cited by 57
Extracorporeal support and hepatocyte transplantation in acute liver failure and cirrhosis
Riordan, S. M., & Williams, R. L. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01945.x · Cited by 53
Review article: liver support systems in acute hepatic failure
Rahman, & Hodgson (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00597.x · Cited by 52
Liu, J., Gluud, L. L., Als-Nielsen, B. E. T., & Gluud, C. N. (2002) · Liver International · doi:10.1034/j.1600-0676.2002.01554.x · Cited by 30
Self-citation
Cited by
Sarin, S. K., Kedarisetty, C. K., Abbas, Z., Amarapurkar, D., Bihari, C., Chan, A. C. Y., Chawla, Y. K., Dokmeci, A. K., Garg, H., Ghazinyan, H., et al. (2014) · Hepatology International · doi:10.1007/s12072-014-9580-2 · Cited by 1,481
AASLD position paper: The management of acute liver failure†
Polson, J., & Lee, W. M. (2005) · Hepatology · doi:10.1002/hep.20703 · Cited by 974
APASL ACLF Research Consortium (AARC) for APASL ACLF working Party., Sarin, S. K., Choudhury, A., Sharma, M. K., Maiwall, R., Al Mahtab, M., Rahman, S., Saigal, S., Saraf, N., Soin, A. S., et al. (2019) · Hepatology International · doi:10.1007/s12072-019-09946-3 · Cited by 884
Acute liver failure: Summary of a workshop†
Lee, W. M., Squires, R. H., Nyberg, S. L., Doo, E., & Hoofnagle, J. H. (2008) · Hepatology · doi:10.1002/hep.22177 · Cited by 757
Bias in clinical intervention research.
Gluud, L. L. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj069 · Cited by 636
Self-citation
Metadata
- Authors
- Kjaergard, L. L., Liu, J., Als-Nielsen, B., & Gluud, C.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2003-01-08
- Volume
- 289
- Issue
- 2
- Pages
- 217
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1995636701
- Cited by
- 379
- References
- 32
- FWCI
- 19.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.